Picture of Hanmi Pharm logo

128940 — Hanmi Pharm News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Brief: Hanmi Pharm's Partner Co Lilly To Return Exclusive Licence To Hanmi Pharm

Jan 23 (Reuters) - Hanmi Pharm Co Ltd  128940.KS :
    * SAYS PARTNER CO ELI LILLY AND CO DECIDES TO RETURN
EXCLUSIVE
LICENCE OF ARTHRITIS DRUG TO HANMI PHARM
    * SAYS LILLY ABANDONED TRIALS OF ARTHRITIS DRUG ON LOW
CHANCE OF
SHOWING EFFICACY IN FEB 2018
    * SAYS LILLY DECIDED TO RETURN LICENCE AFTER REVIEWING TRIAL
DATA
AND ARTHRITIS DRUG MARKET IN JAN

Source text for Eikon: https://bit.ly/2S14LMF
Further company coverage:  128940.KS 

 ((Reuters Messaging: joori.roh.thomsonreuters.com@reuters.net))

Recent news on Hanmi Pharm

See all news